dc.contributor.author |
Painschab, M.S. |
|
dc.contributor.author |
Malpartida, G.E. |
|
dc.contributor.author |
Dávila-Roman, V.G. |
|
dc.contributor.author |
Gilman, Robert Hugh |
|
dc.contributor.author |
Kolb, T.M. |
|
dc.contributor.author |
León-Velarde, Fabiola |
|
dc.contributor.author |
Miranda, J. Jaime |
|
dc.contributor.author |
Checkley, W. |
|
dc.date.accessioned |
2019-02-22T14:55:00Z |
|
dc.date.available |
2019-02-22T14:55:00Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/5702 |
|
dc.description.abstract |
Long-term residence at high altitude is associated with the development of chronic mountain sickness (CMS), which is characterized by excessive erythrocytosis (EE). EE occurs under chronic hypoxia, and a strongly selected mutation in hypoxia-inducible factor 2α (HIF2A) has been found in native Tibetans that correlates with having a normal hemoglobin at high altitude. We sought to evaluate differences in plasma levels of four HIF-responsive proteins in 20 participants with EE (hemoglobin >21 g/dL in men and >19 in women) and in 20 healthy, age- and sex-matched participants without EE living at high altitude in Puno, Peru. We performed ELISA to measure plasma levels of the four HIF-responsive proteins: vascular endothelial growth factor (VEGF), soluble VEGF receptor 1 (sVEGF-R1), endothelin-1, and erythropoietin. As a secondary aim, we evaluated the association between HIF-responsive proteins and echocardiography-estimated pulmonary artery systolic pressure (PASP) in a subset of 26 participants. sVEGF-R1 was higher in participants with vs. without EE (mean 107 pg/mL vs. 90 pg/mL; p=0.007). Although plasma concentrations of endothelin-1, VEGF, and erythropoietin were higher in participants with vs. without EE, they did not achieve statistical significance (all p>0.25). Both sVEGF-R1 (p=0.04) and erythropoietin (p=0.04) were positively associated with PASP after adjustment for age, sex, and BMI. HIF-responsive proteins may play a pathophysiological role in altitude-related, chronic diseases but our results did not show consistent changes in all measured HIF-responsive proteins. Larger studies are needed to evaluate for additional genetic and environmental risk factors. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
Mary Ann Liebert |
|
dc.relation.ispartofseries |
High Altitude Medicine and Biology |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Peru |
en_US |
dc.subject |
Adult |
en_US |
dc.subject |
Female |
en_US |
dc.subject |
Humans |
en_US |
dc.subject |
Male |
en_US |
dc.subject |
chronic mountain sickness |
en_US |
dc.subject |
Aged |
en_US |
dc.subject |
Middle Aged |
en_US |
dc.subject |
Altitude |
en_US |
dc.subject |
Altitude Sickness |
en_US |
dc.subject |
Polycythemia |
en_US |
dc.subject |
Case-Control Studies |
en_US |
dc.subject |
Blood Pressure |
en_US |
dc.subject |
pulmonary artery |
en_US |
dc.subject |
Pulmonary Artery |
en_US |
dc.subject |
erythrocytosis |
en_US |
dc.subject |
polycythemia |
en_US |
dc.subject |
excessive erythrocytosis |
en_US |
dc.subject |
erythropoietin |
en_US |
dc.subject |
hypoxia |
en_US |
dc.subject |
blood pressure |
en_US |
dc.subject |
altitude |
en_US |
dc.subject |
Biomarkers |
en_US |
dc.subject |
human |
en_US |
dc.subject |
adult |
en_US |
dc.subject |
aged |
en_US |
dc.subject |
female |
en_US |
dc.subject |
male |
en_US |
dc.subject |
middle aged |
en_US |
dc.subject |
Article |
en_US |
dc.subject |
priority journal |
en_US |
dc.subject |
Hypoxia |
en_US |
dc.subject |
controlled study |
en_US |
dc.subject |
blood |
en_US |
dc.subject |
echocardiography |
en_US |
dc.subject |
altitude disease |
en_US |
dc.subject |
pulmonary hypertension |
en_US |
dc.subject |
biological marker |
en_US |
dc.subject |
case control study |
en_US |
dc.subject |
VEGF |
en_US |
dc.subject |
clinical article |
en_US |
dc.subject |
hypoxia inducible factor |
en_US |
dc.subject |
physiology |
en_US |
dc.subject |
protein expression |
en_US |
dc.subject |
vasculotropin receptor 1 |
en_US |
dc.subject |
enzyme linked immunosorbent assay |
en_US |
dc.subject |
Erythropoietin |
en_US |
dc.subject |
C reactive protein |
en_US |
dc.subject |
systolic blood pressure |
en_US |
dc.subject |
basic helix loop helix transcription factor |
en_US |
dc.subject |
Basic Helix-Loop-Helix Transcription Factors |
en_US |
dc.subject |
endothelial PAS domain-containing protein 1 |
en_US |
dc.subject |
endothelin 1 |
en_US |
dc.subject |
Endothelin-1 |
en_US |
dc.subject |
EPO |
en_US |
dc.subject |
HIF |
en_US |
dc.subject |
lung artery pressure |
en_US |
dc.subject |
protein blood level |
en_US |
dc.subject |
Vascular Endothelial Growth Factor Receptor-1 |
en_US |
dc.subject |
Vascular Endothelial Growth Factors |
en_US |
dc.subject |
vasculotropin |
en_US |
dc.title |
Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.1089/ham.2014.1086 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.01.08 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.11 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.03.05 |
|
dc.relation.issn |
1557-8682 |
|